Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Aurinia Pharmaceuticals Inc
About AUPH
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. It has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis (LN) and continues to conduct clinical and regulatory activities to support the LUPKYNIS development program. The Company is also developing aritinercept (AUR200), a dual inhibitor of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) for the potential treatment of autoimmune diseases. It sells LUPKYNIS to specialty pharmacies and a specialty distributor in the United States and sells LUPKYNIS inventory to its collaboration partner, Otsuka Pharmaceutical Co., Ltd. (Otsuka), for the European and Japanese market. The Company sells encapsulated voclosporin to its collaboration partner, Otsuka, which Otsuka then sells to customers in its territories.
Find out what a historical investment in Aurinia Pharmaceuticals Inc would be worth today using our AUPH stock calculator.
Market Capitalisation
$2.00B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.35M
High today
$15.99
Low today
$15.28
Open price
$15.35
52-week high
$16.88
52-week low
$7.29
Ready to start your investing journey with Stake?
Open an accountHow do I buy AUPH shares in Australia?
Buying AUPH shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Aurinia Pharmaceuticals Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in AUPH
What is the ticker symbol of Aurinia Pharmaceuticals Inc?
The ticker symbol for Aurinia Pharmaceuticals Inc is AUPH.
How much is one share of AUPH?
One share of AUPH is valued at $15.91 as of 20 May 2026.
What is the market capitalisation of Aurinia Pharmaceuticals Inc AUPH?
As of 20 May 2026 Aurinia Pharmaceuticals Inc has a market cap of $2.00B.
What is the P/E ratio of AUPH?
The Price to Earnings ratio of AUPH is 7.18.
What is the Earnings Per Share of AUPH?
The Earnings Per Share of AUPH is $2.17.
What is the 52-week high for Aurinia Pharmaceuticals Inc stock?
The Aurinia Pharmaceuticals Inc 52-week high stock price is $16.88.
What is the 52-week low for Aurinia Pharmaceuticals Inc stock?
The Aurinia Pharmaceuticals Inc 52-week low stock price is $7.29.
Can I buy AUPH shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy AUPH shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in AUPH on Stake
- Buy AUPH from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of AUPH from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
AUPH related stocks